Moderna has not been distributing its vaccines fast enough internationally. There is a timer to these things you know, because the virus can mutate more. For that reason I'd rather put my investment in 3D printing or something.
Since the results of the regulatory tests and safety and efficacy validations can mostly be transferred for slight vaccine modifications (at least that's my state of knowledge), a variation should not have to go through the entire chain of test phases again before it can be cleared for use.
If anything, the prospect of mutations can only be seen as a significant moat for mRNA vaccine manufacturers, because their technology is the fastest when it comes to such adaptions.
Is that kinda like saying the 737-MAX wasn't really a new type of plane?